Clinical Trial Update: Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating adoptive immunotherapy with autologous ex vivo expanded regulatory CD8+ T cells in living-donor kidney transplant recipients; status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Autologous ex vivo expanded regulatory CD8+ T cells

Snippet

Sponsor: Nantes University Hospital | Conditions: Kidney Transplantation | Phase 1 | Status: NOT_YET_RECRUITING